Transformational M&A Not On Horizon For Haleon Or Bayer

Haleon CEO Brian McNamara and Bayer Consumer Health president Julio Triana independently tell the Barclays Consumer Conference that their respective firms are unlikely to secure any transformational mergers or acquisitions in the medium term. Both companies are prioritizing bolt-on acquisitions for the next few years.

• Source: Shutterstock

Even though the global consumer health market remains highly fragmented two of the largest players say they don’t expect to strike any transformational deals any time soon.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business